vVardis Overview
- Year Founded
-
2020
- Status
-
Public
- Employees
-
153
- Stock Symbol
-
VVVV
- Investments
-
1
- Share Price
-
$16.50
- (As of Friday Closing)
vVardis General Information
Description
Vvardis Holding AG is a disruptive Swiss healthcare company that engages in research and development as well as business activities to manufacture, sell and distribute dental care products. The company's proprietary peptide-enabled technology platform, Curodont, delivers an early therapeutic solution for tooth decay. Its revenue includes sales of dental care products. Geographically, the maximum revenue of the company is derived from the United States, and the rest from Switzerland, Italy and the United Kingdom.
Contact Information
Website
www.vvardis.comCorporate Office
- Gubelstrasse 24
- 6300 Zug
- Switzerland
Corporate Office
- Gubelstrasse 24
- 6300 Zug
- Switzerland
vVardis Timeline
vVardis Stock Performance
As of 13-Nov-2026, vVardis’s stock price is $16.50. Its current market cap is $2.99B with 181M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.50 | $14.00 - $16.94 | $2.99B | 181M | 3.77M | -$0.29 |
vVardis Financials Summary
As of 30-Jun-2026, vVardis has a trailing 12-month revenue of $49.7M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| Revenue | 49,679 | 30,209 | 12,157 |
| EBITDA | (31,799) | (41,104) | (27,298) |
| Net Income | (52,244) | (56,494) | (34,737) |
| Total Assets | 104,803 | 83,228 | 55,907 |
| Total Debt | 86,368 | 107,057 | 73,009 |
vVardis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
vVardis Patents
vVardis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4799601-A1 | Encapsulated compositions for dental and bone remineralisation | Pending | 27-Feb-2025 | ||
| WO-2026180716-A2 | Encapsulated compositions for dental and bone remineralisation | Pending | 27-Feb-2025 | ||
| WO-2026180716-A3 | Encapsulated compositions for dental and bone remineralisation | Pending | 27-Feb-2025 | ||
| CA-239924-S | Blister pack | Active | 28-Oct-2024 | ||
| US-D1147852-S1 | Blister pack | Active | 28-Oct-2024 |
vVardis Signals
vVardis Acquisitions (1)
vVardis’s most recent deal was a Merger/Acquisition with Credentis. The deal was made on 09-Dec-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Credentis | 09-Dec-2020 | Merger/Acquisition | Pharmaceuticals |
vVardis FAQs
-
When was vVardis founded?
vVardis was founded in 2020.
-
Where is vVardis headquartered?
vVardis is headquartered in Zug, Switzerland.
-
What is the size of vVardis?
vVardis has 153 total employees.
-
What industry is vVardis in?
vVardis’s primary industry is Personal Products.
-
Is vVardis a private or public company?
vVardis is a Public company.
-
What is vVardis’s stock symbol?
The ticker symbol for vVardis is VVVV.
-
What is the current stock price of vVardis?
As of 13-Nov-2026 the stock price of vVardis is $16.50.
-
What is the current market cap of vVardis?
The current market capitalization of vVardis is $2.99B.
-
What is vVardis’s current revenue?
The trailing twelve month revenue for vVardis is $49.7M.
-
What is vVardis’s annual earnings per share (EPS)?
vVardis’s EPS for 12 months was -$0.29.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process